Sometimes a story hits your right in the heart. Matt Fogg’s experience with battling chronic heart failure to eventually overcoming it is one of those.
Typically, when patients receive a left ventricular assist device (LVAD), it serves as either a bridge to transplant, or as a lifetime therapy if the patient is not a candidate for transplantation. But one Brigham and Women’s Hospital (BWH) patient became the hospital’s first chronic implant patient in recent years to successfully recover heart function with targeted therapy and, ultimately, have the device removed.
When Fogg, now 24, arrived at BWH two years ago, he was suffering from heart failure. His heart was so damaged that it was unable to provide enough blood to his organs. After Matt had received care at BWH for a month, cardiologist Dr. Eldrin Lewis of the Center for Advanced Heart Disease advocated for him to have an LVAD implanted. “Given that Matt was so young, we thought he would do well on an LVAD,” says Lewis.